• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Half-life time or clearance of indocyanine green in patients with liver disease.

作者信息

Gilmore I T, Marigold J H, Thompson R P

出版信息

Hepatogastroenterology. 1982 Apr;29(2):55-7.

PMID:7084884
Abstract

The clearance, half-life time, fractional elimination rate and distribution volume of indocyanine green (10 mg . m-2) were measured in 20 control subjects and 63 patients with histologically confirmed liver disease. Mean clearance was significantly impaired only in the patients with alcoholic and primary biliary cirrhosis; in those with active chronic hepatitis, with or without cirrhosis, or with acute hepatitis, clearance was normal. However, half-life time and fractional elimination rate were impaired in all but one group of patients. This discrepancy arose because of a significantly increased distribution volume in all groups with chronic liver diseases except primary biliary cirrhosis. Thus, in chronic liver disease, half-life times and fractional elimination rates do not necessarily reflect hepatic uptake; measurement of clearance is therefore to be preferred.

摘要

相似文献

1
Half-life time or clearance of indocyanine green in patients with liver disease.
Hepatogastroenterology. 1982 Apr;29(2):55-7.
2
Normal metabolism of morphine in cirrhosis.肝硬化中吗啡的正常代谢
Gastroenterology. 1981 Dec;81(6):1006-11.
3
[Hepatic clearance of 99mTc-p-butyl HIDA in liver diseases. Correlations with routine hematochemical parameters of liver function].
Minerva Med. 1984 Nov 3;75(42):2527-32.
4
Pharmacokinetic study on the hepatic uptake of indocyanine green in cirrhotic patients.肝硬化患者肝脏摄取吲哚菁绿的药代动力学研究。
Am J Gastroenterol. 1985 Oct;80(10):801-6.
5
Colchicine clearance is impaired in alcoholic cirrhosis.
Hepatology. 1991 Dec;14(6):1013-5.
6
The effects of age and liver disease on the disposition and elimination of diazepam in adult man.年龄和肝脏疾病对成年男性体内地西泮处置与消除的影响。
J Clin Invest. 1975 Feb;55(2):347-59. doi: 10.1172/JCI107938.
7
Cefoperazone pharmacokinetics in patients with liver cirrhosis: a predictive value of the ujoviridin test.
Int J Clin Pharmacol Ther Toxicol. 1989 Feb;27(2):82-7.
8
[Liver metabolism of indocyanine green and aminopyrine in liver cirrhosis: relations with functioning liver cell mass].[肝硬化患者肝脏中吲哚菁绿和氨基比林的代谢:与功能性肝细胞量的关系]
Minerva Med. 1988 Dec;79(12):1035-41.
9
Pharmacokinetics of famotidine after intravenous administration in liver disease.
Am J Gastroenterol. 1991 Jan;86(1):41-5.
10
[Different elimination velocity of indocyanine green in liver diseases of various severity].[不同严重程度肝脏疾病中吲哚菁绿的不同消除速度]
Z Gesamte Inn Med. 1973 Sep 1;28(17):523-6.

引用本文的文献

1
Prediction of Survival After Partial Hepatectomy Using a Physiologically Based Pharmacokinetic Model of Indocyanine Green Liver Function Tests.使用基于生理的吲哚菁绿肝功能测试药代动力学模型预测肝部分切除术后的生存率
Front Physiol. 2021 Nov 22;12:730418. doi: 10.3389/fphys.2021.730418. eCollection 2021.
2
True versus mild hyperthermia during isolated hepatic perfusion: effects on melphalan pharmacokinetics and liver function.离体肝脏灌注期间真性与轻度体温过高:对美法仑药代动力学及肝功能的影响。
World J Surg. 2004 Aug;28(8):775-81. doi: 10.1007/s00268-004-7430-4. Epub 2004 Aug 3.
3
Chemically induced hepatitis after inhaling organic solvents.
吸入有机溶剂后化学性诱导的肝炎
West J Med. 1988 Apr;148(4):458-60.
4
Famotidine does not affect indocyanine green disposition and serum bile acid levels in healthy subjects.法莫替丁不影响健康受试者体内吲哚菁绿的代谢及血清胆汁酸水平。
Br J Clin Pharmacol. 1987 Jun;23(6):779-80.